| Benefits of Medroxyprogesterone Acetate (MPA) in Advanced or Recurrent Breast Cancer with Higher Serum Concertration. | |
| | |
MedLine Citation:
|
PMID: 11091543 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The efficacy of medroxyprogesterone acetate (MPA) therapy in controlling progressive measurable metastatic breast cancer was assessed in 61 patients. In addition serum MPA concentrations were measured by high performance liquid chromatography (HPLC) and subjective effects of treatment were monitored. Overall 24 patients (39.3%) achieved an objective response(2 complete responses [ CR ] and 22 partial responses [ PR ]). There was no significant relationships between response to therapy and menopausal status, metastatic sites, previous therapy, histological type, or disease-free interval. Patients with estrogen (ER) and progesterone (PgR) receptor-positive tumors responded more frequently. Significant differences in serum MPA concentrations were seen between responders and non-responders, objective tumor shrinkage being seen in patients with serum levels in excess of 55 ng/ml. There were few cases responding to the therapy with serum MPA concentrations lower than 25 ng/ml. The serum MPA levels significantly correlated with an improvement in the performance status and survival. Patients with serum MPA concentrations lower than 25 ng/ml had significantly poorer survival. There was a significant relationship between MPA level and dose per area of boby surface (mg/ m(2)) in cases with CR or PR or no change (NC). However, the serum levels of patients with progressive disease despite therapy were lower than the expected levels based on the body surface area. This study demonstrated that serum MPA concentration is a determining factor for therapeutic benefit in advanced or recurrent breast cancer. |
| | |
Authors:
|
Nishimura; Nagao; Matsuda; Baba; Matsuoka; Yamashita; Fukuda; Higuchi; Saiki |
Related Documents
:
|
21641133 - Attenuation of luteolytic response following fish meal supplementation in dairy buffalo... 21988613 - Influence of sexual stimulation and the administration of human chorionic gonadotrophin... 2110423 - Ischemia in normoglycemic and hyperglycemic rats: plasma energy substrates and hormones. |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Breast cancer (Tokyo, Japan) Volume: 2 ISSN: 1880-4233 ISO Abbreviation: Breast Cancer Publication Date: 1995 Oct |
Date Detail:
|
Created Date: 2000-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888201 Medline TA: Breast Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: 133-141 Citation Subset: - |
Affiliation:
|
Department of Surgery, Kumamoto City Hospital, 1-1-60 Kotoh, Kumamoto 862, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Decision Making Using Postoperative CEA and CA 15-3 for Detection of Breast Cancer Recurrence.
Next Document: Medical Economics and Quality of Life: Analysis of Factors That Influence the Perception of Medical ...